BioCentury
ARTICLE | Clinical News

Flagellin: Preliminary Phase II data

May 3, 2010 7:00 AM UTC

VaxInnate Corp., Cranbury, N.J. Product: Flagellin.AvHA ( VAX125) Business: Infectious Molecular target: Influenza A virus hemagglutinin Description: Flu vaccine linking hemagglutinin (HA) to flagel...